Related Experiment Videos
[Clinical and therapeutic aspects of Kawasaki disease. Clinical contribution]
L Massimo1, F Di Luna, R Sottile
1S.S.N.-Regione Campania, Napoli-USL n. 40, Presidio Ospedaliero Santobono, Italia.
Insights
This study followed four Kawasaki disease patients, observing significant immune system issues. Prompt treatment with aspirin (ASA) and intravenous immunoglobulin (Ig) led to rapid symptom remission.
Area of Science:
- Pediatrics
- Immunology
- Cardiology
Background:
- Kawasaki disease (KD) is an acute febrile illness primarily affecting young children.
- KD can lead to serious cardiac complications, including coronary artery aneurysms.
- Understanding KD's immunological basis and effective treatment is crucial.
Observation:
- Four patients with Kawasaki disease were monitored for 6-10 months.
- Marked immunological disorders were observed in all subjects.
- Echocardiography revealed coronary artery microaneurysms in one patient, persisting without clinical correlation.
Findings:
- All patients exhibited significant immunological abnormalities.
- Coronary artery microaneurysms were detected in one patient via echocardiography.
- Rapid remission of clinical and humoral manifestations occurred following treatment.
Implications:
- Intravenous immunoglobulin (Ig) combined with aspirin (ASA) demonstrates rapid efficacy in treating Kawasaki disease.
- Early detection and management are vital for preventing long-term cardiac sequelae.
- Further research into KD's immunopathogenesis may reveal novel therapeutic targets.
Abstract:
Four subjects, three males and one female, suffering from Kawasaki disease, were studied clinically, immunologically and instrumentally since from the early stages of the disease through 6-10 months. According to data reported in the literature, all the patients showed marked immunological disorders. Microaneurysms of coronary vessels were detected by echocardiography in one of the patients; such finding, constantly present through the follow-up, did not have any clinical and/or electrocardiographic correlate. Moreover, it is worth recording the rapid remission in all subjects of the principal clinical and humoral systems following the treatment with ASA + high dosage Ig given via intravenous.